There is no better time for a Special Issue on Novel Psychoactive Substances (NPS).
Over the last decade there has been a dramatic and unprecedented increase in the number of new drugs discovered or synthesized. This has become a matter of global concern, since these novel substances comprise a serious threat to public health. NPS have become rapidly available in the drug market with barely any knowledge about their side effects, toxicity, or the health risks they pose to users. Misleadingly called "legal highs" , NPS are often advertised on the Internet as "legal and safer" alternatives to illicit drugs. They also appear as increasingly sophisticated chemical structures, with many potential adverse effects on health and well-being. Substances. Like the three previous NPS conferences Parrott and Corazza, 2015) , this special issue is being published in the leading international journal for NPS research: 'Human Psychopharmacology'.
Cited by thousands of colleagues working in the field, the growing success of our collective effort has been confirmed by the largest number of contributions for this latest Issue. Each contribution presents some unique insights into this complex field; they include insights into drug detection, performance assessment, neurocognitive and other adverse consequences, epidemiology, subjective experiences, and many others.
Attention is also paid to emerging topics of discussion, such as the role played by the digital world in driving sudden changes in patterns of substance abuse, and providing novel mechanisms for global marketing and drug sales. The Internet has facilitated access to information on chemical synthesis, which has enabled amateur chemists to stay ahead of the regulators by rapidly generating many novel chemical structures. It has also enabled the sharing of experiences between consumers, with some sites hosting discussion forums, while others provide mechanisms for buyer feedback and subjective ratings. Analyses of the most hidden aspects of the net, such as the spread of NPS within the deep and dark webs, will also be offered.
Overall, we hope that this NPS Special Issue sheds some new light on this rapidlychanging drug scenario. We believe it is crucial to share and enhance all our multidisciplinary knowledge in this field. Hopefully we may also anticipate some of the forthcoming challenges, in order to be optimally prepared for the future. Please read and enjoy.
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